-
Trump's face could appear on US $250 bill
-
Mistral says would not interfere if its AI is used by defence customers
-
Canada PM backs 'fortress North America' ahead of US trade talks
-
Flooding in north and east Syria as Euphrates level rises
-
Defending champion Gauff reaches French Open third round
-
Musk defends AI ambitions as IPO reveals trouble
-
Five things to know about heatwaves in Europe
-
Israel freezes out UN chief over sexual violence blacklist
-
US, Iran agree deal framework but need Trump sign-off: sources
-
Italy on red alert as France, Portugal beat hottest May day record
-
Oil advances, stocks drift on fresh US-Iran strikes
-
'Terrorist' knife attack wounds 3 at Swiss train station: official
-
'You are not alone' in Ebola fight, vows DR Congo-bound WHO chief
-
Sinner 'hits wall' as French Open bid collapses
-
France's Magnier sprints to Giro 18th stage win, Vingegaard in pink
-
Top EU economies vow to speed up financial integration
-
Israeli strike near Beirut as Lebanon says raids kill 14
-
Mosquitoes can learn to love common repellent, scientists find
-
US revises first quarter growth down while inflation climbs
-
Italy on red alert as Portugal beats record for hottest May day
-
Latvia gets new centre-right govt after row over stray Ukraine drones
-
France's Kouame, 17, youngest man into Slam third round since Nadal
-
Netflix criticises German plan to make streamers invest more locally
-
'Dizzy' Sinner wilts in French Open heat, out in second round
-
Ailing Sinner crashes out of French Open, Sabalenka waits
-
Italy on red alert as heatwave bakes Europe
-
UK risks a 'lost generation' of jobless young people
-
Attacker wounds three at Swiss train station with 'bladed weapon'
-
Neymar a doubt for Brazil's World Cup opener due to injury
-
Norway's Queen leaves hospital amidst mounting fears over princess
-
US, Iran accuse each other of violating truce after attacks
-
France inches towards symbolic repealing of slavery legislation
-
Oil climbs, stocks drop on fresh US-Iran strikes
-
Scotland boss Clarke signs new four-year contract
-
Italian police seize $232 mn in late mafia boss's assets
-
EU fines Temu 200 mn euros over illegal products
-
Fire in Kenya girls' school dorm kills 16
-
French AI firm Mistral announces deals with BMW, Airbus
-
US, Iran trade strikes in most serious clash since truce began
-
'Immense' leverage: why AI chip workers are demanding more
-
Online horror phenomenon turns movie blockbuster with 'Backrooms'
-
Latvia to get new govt after row over stray drones
-
Oil rises and Asia stocks slide after new US strikes on Iran
-
France moves towards symbolic repealing of slavery legislation
-
'Six machine' Sooryavanshi, 15, stakes India claim with new stunning knock
-
China's military says drove away Dutch warship in South China Sea
-
Israel strikes Tyre after declaring 'combat zones' in south Lebanon
-
US strikes Iran, drawing retaliatory attack on American base
-
Temperatures likely to remain at record levels in 2026-2030: UN
-
New Zealand boosts defence spending in face of 'adverse' security environment
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
P.AbuBaker--SF-PST